Healthcare Blogs

Medical Articles & Exam Preparation Guides

In-depth clinical insights, Royal College exam strategies, case studies, and career advancement guides for medical professionals.

Articles — Page 220

Showing Page 220 of 287 (3435 Articles)
Indian doctor discussing New Rivaroxaban Data: Is Prophylaxis Safe for Breastfeeding?Obstetrics and Gynaecology

New Rivaroxaban Data: Is Prophylaxis Safe for Breastfeeding?

New data supports Rivaroxaban breastfeeding safety for postpartum thromboprophylaxis. The relative infant dose was 2.9%, well below the 10% safety threshold. This low neonatal exposure suggests a low-risk option.

Dec 19, 2025
3 min read
Indian doctor discussing Robotic Physiotherapy: The Future of High-Tech Care in IndiaMedical Updates

Robotic Physiotherapy: The Future of High-Tech Care in India

Robotic Physiotherapy is revolutionizing rehabilitation in India. Discover how 'Make in India' robots are providing precise, cost-effective, and data-driven care for lifestyle and neurological disorders.

Dec 18, 2025
4 min read
Indian doctor discussing Medanta’s Varian EDGE: A Leap Forward in Ultra-Precision RadiotherapyMedical Updates

Medanta’s Varian EDGE: A Leap Forward in Ultra-Precision Radiotherapy

Medanta has become the first hospital in India to install the advanced Varian EDGE system, revolutionizing cancer care with ultra-precise Precision Radiotherapy. It features IDENTIFY SGRT and HyperArc to deliver treatment in under a minute with sub-millimetric accuracy.

Dec 18, 2025
4 min read
Indian doctor discussing How ABDM 2.0, FDI, and GLP-1 Drugs are Reshaping India’s HealthMedical Updates

How ABDM 2.0, FDI, and GLP-1 Drugs are Reshaping India’s Health

India's health sector saw tectonic shifts in 2025. Key changes include the launch of ABDM 2.0, 100% FDI in insurance, and the wider access to GLP-1 therapies, moving care upstream.

Dec 18, 2025
6 min read
Indian doctor discussing AI Reclassifies Grade 2 Breast Tumors, Guiding Treatment DecisionsRadiology

AI Reclassifies Grade 2 Breast Tumors, Guiding Treatment Decisions

A new deep learning model (DeepRadGrade) uses DCE-MRI for NHG2 risk stratification in breast cancer, identifying high-risk tumors to guide personalized treatment.

Dec 18, 2025
4 min read
Indian doctor discussing Unmasking the Silent Threat: PAVM Risk Factors for StrokeRadiology

Unmasking the Silent Threat: PAVM Risk Factors for Stroke

CT-based analysis reveals key anatomic predictors of stroke and brain abscess in solitary pulmonary AVMs (PAVMs). Larger feeding arteries pose a higher risk.

Dec 18, 2025
4 min read
Indian doctor discussing Why Nomograms Are Essential for Lung Cancer Staging TodayRadiology

Why Nomograms Are Essential for Lung Cancer Staging Today

A nomogram combining clinical data, CT, and PET findings accurately predicts lymph node metastasis in primary lung cancer, aiding staging and treatment.

Dec 18, 2025
3 min read
Indian doctor discussing DECT: Why Virtual Non-Contrast is Safer for GI BleedingRadiology

DECT: Why Virtual Non-Contrast is Safer for GI Bleeding

A new study confirms that Dual-Energy CT (DECT) with Virtual Non-Contrast (VNC) is non-inferior to conventional triphasic CT for GI bleeding diagnosis. This technique also reduces radiation and reading time.

Dec 18, 2025
3 min read
Indian doctor discussing New Deep Learning Tool Predicts Low Back Pain DisabilityRadiology

New Deep Learning Tool Predicts Low Back Pain Disability

A deep learning model accurately quantifies paraspinal muscle degeneration (fat fraction) in CLBP patients, revealing that muscle function mediates the link between muscle loss and disability.

Dec 18, 2025
3 min read
Indian doctor discussing Critical Trial Update: Tirzepatide vs. Dulaglutide for CV RiskInternal Medicine

Critical Trial Update: Tirzepatide vs. Dulaglutide for CV Risk

The SURPASS-CVOT trial found that Tirzepatide CV outcomes were noninferior to dulaglutide in patients with type 2 diabetes and ASCVD. Learn key clinical takeaways.

Dec 18, 2025
3 min read
Indian doctor discussing Revolutionizing Oncology: Circadian Rhythm Can Shrink TumoursMedical Updates

Revolutionizing Oncology: Circadian Rhythm Can Shrink Tumours

Research shows fixing the body's natural Circadian Rhythm in mice with breast cancer can significantly shrink tumours by boosting immunity. This may revolutionize chronotherapy.

Dec 17, 2025
4 min read
Indian doctor discussing Better Risk Prediction for Monochorionic Twin PregnanciesObstetrics and Gynaecology

Better Risk Prediction for Monochorionic Twin Pregnancies

A new prediction model using EFW and Doppler discordance significantly improves the assessment of monochorionic twin outcome risks, surpassing current sFGR classification. This research aids in optimizing birth timing.

Dec 17, 2025
4 min read
Page 220 of 287

Subscribe to OC Academy Medical Journal

Get the latest Royal College exam tips, clinical guidelines, and course updates delivered straight to your inbox.